Europe Exosomes Market Size & Outlook, 2023-2030
Europe exosomes market, 2018-2030 (US$M)
Related Markets
Europe exosomes market highlights
- The Europe exosomes market generated a revenue of USD 29.8 million in 2023.
- The market is expected to grow at a CAGR of 32.5% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 29.8 million |
| Market revenue in 2030 | USD 213.9 million |
| Growth rate | 32.5% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Instruments, Services |
| Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
Other key industry trends
- In terms of revenue, Europe region accounted for 21.1% of the global exosomes market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 615.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exosomes Market Scope
Exosomes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe exosomes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exosomes market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 45.64% in 2023. Horizon Databook has segmented the Europe exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
The exosome research market is growing rapidly owing to the growth of nationally-funded projects on micro vesicles and exosomes throughout Europe. Several endeavors are being undertaken to create a network of European experts with an objective to foster the basic understanding as well as the translational potential of these molecules in this region.
Moreover, European entities are developing forums for the exchange of information and to train young European researchers for the isolation and analysis of exosomes. The presence of key players, such as Lonza and Re Neuron Group PLC, has significantly contributed to the share of this regional market.
For instance, in May 2017, Lonza completed the acquisition of Hansa BioMed LS, a company focused on the isolation and analysis of extracellular vesicles. In May 2014, Exiqon A/S, a subsidiary of Qiagen, launched an exosome isolation kit for the isolation of exosomes from cell media and various biofluids.
Reasons to subscribe to Europe exosomes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe exosomes market databook
-
Our clientele includes a mix of exosomes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe exosomes market , including forecasts for subscribers. This continent databook contains high-level insights into Europe exosomes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe exosomes market size, by country, 2018-2030 (US$M)
Europe Exosomes Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
